Instil Bio
77 hedge funds and large institutions have $1.99B invested in Instil Bio in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 10 reducing their positions, and 5 closing their positions.
280% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 5
230% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 10
55% more capital invested
Capital invested by funds: $1.28B → $1.99B (+$700M)
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
20% more funds holding
Funds holding: 64 → 77 (+13)
1.71% more ownership
Funds ownership: 2.79% → 4.5% (+1.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$47.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$47.1M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$23.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$9.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$22.8M |
| 2 |
DM
Deerfield Management
New York
|
-$19.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.62M |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$2.96M |
| 5 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
-$1.75M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $468 | +$319K | +827 | +153% |
|
|
LGM
77
Logos Global Management
San Francisco,
California
| – | -$22.8M | -63,855 | Closed |
|
|
DM
78
Deerfield Management
New York
| – | -$19.9M | -55,787 | Closed |
|
|
BPA
79
Beacon Pointe Advisors
Newport Beach,
California
| – | -$1.75M | -4,890 | Closed |
|
|
E
80
Ergoteles
New York
| – | -$1.43M | -3,996 | Closed |
|
81
Balyasny Asset Management
Chicago,
Illinois
| – | -$472K | -1,319 | Closed |
|
|
C
82
Covestor
London,
United Kingdom
| – | +$386 | +1 | New |
|
TIL Hedge Fund Activity: Q4 2021 in Review
77 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q4 2021, worth a combined $1.99B — up 55% from $1.28B a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new TIL positions and 5 closed out — a net gain of 14 holders — while 33 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $47.2M. The largest seller was Logos Global Management, exiting entirely with an estimated $22.8M sold.
- 77 institutional investors held Instil Bio (TIL) as of Q4 2021, up from 64 in Q3 2021.
- Funds reported $1.99B of Instil Bio stock for Q4 2021, up 55% quarter-over-quarter.
- 19 funds opened new Instil Bio positions in Q4 2021 and 5 closed out, a net change of +14 holders.
- The largest Instil Bio buyer in Q4 2021 was BlackRock, an estimated $47.2M added.
- The largest Instil Bio seller in Q4 2021 was Logos Global Management, an estimated $22.8M sold.
Based on aggregated 13F filings for Q4 2021.